Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
University of Alabama at Birmingham
AstraZeneca
PinkDx, Inc.
AstraZeneca
Genmab
Imperial College London
Northwestern University
M.D. Anderson Cancer Center